(ZETA) Zeta Global Holdings - Overview
Stock: Marketing Platform, Consumer Data, Agile Intelligence, Data Analytics
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 77.6% |
| Relative Tail Risk | -8.81% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.01 |
| Alpha | -37.76 |
| Character TTM | |
|---|---|
| Beta | 2.044 |
| Beta Downside | 2.282 |
| Drawdowns 3y | |
|---|---|
| Max DD | 70.01% |
| CAGR/Max DD | 0.36 |
Description: ZETA Zeta Global Holdings January 12, 2026
Zeta Global Holdings Corp. (NYSE: ZETA) runs an omnichannel, data-driven cloud platform that delivers consumer intelligence and marketing-automation tools to enterprise clients worldwide. Its flagship Zeta Marketing platform ingests billions of structured and unstructured signals, applies proprietary machine-learning models, and predicts consumer intent using an industry-wide opted-in data set. The complementary Consumer Data Platform (CDP+) supplies real-time identifiers and consolidates internal and external data feeds, enabling marketers to segment audiences and measure performance across channels. Zeta also offers an Agile Intelligence Suite that blends its own data with client-generated data to surface actionable insights for campaign execution.
Key recent metrics (FY 2023): revenue of $281 million, representing a 12 % YoY increase driven largely by higher subscription renewals and expansion into the U.S. mid-market segment; a net-retention rate of ~115 %, indicating strong upsell/cross-sell momentum; and a cash-burn reduction of 18 % year-over-year as the firm scales its AI infrastructure. Sector-wide, digital ad spend in the United States is projected to grow ~9 % annually through 2027, while the adoption of AI-enhanced CDPs is accelerating, with a base-rate adoption of ~22 % among Fortune 500 firms-a trend that underpins Zeta’s growth narrative.
For a deeper, data-driven perspective on Zeta’s valuation and risk profile, you might find ValueRay’s analytical dashboard worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: -22.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 3.07 > 1.0 |
| NWC/Revenue: 37.58% < 20% (prev 49.12%; Δ -11.54% < -1%) |
| CFO/TA 0.16 > 3% & CFO 178.4m > Net Income -22.8m |
| Net Debt (-188.3m) to EBITDA (44.4m): -4.24 < 3 |
| Current Ratio: 3.01 > 1.5 & < 3 |
| Outstanding Shares: last quarter (222.4m) vs 12m ago 18.38% < -2% |
| Gross Margin: 55.19% > 18% (prev 0.54%; Δ 5465 % > 0.5%) |
| Asset Turnover: 121.3% > 50% (prev 103.7%; Δ 17.55% > 0%) |
| Interest Coverage Ratio: -35.59 > 6 (EBITDA TTM 44.4m / Interest Expense TTM 694.0k) |
Altman Z'' -2.99
| A: 0.40 (Total Current Assets 689.1m - Total Current Liabilities 228.8m) / Total Assets 1.15b |
| B: -0.93 (Retained Earnings -1.07b / Total Assets 1.15b) |
| C: -0.02 (EBIT TTM -24.7m / Avg Total Assets 1.01b) |
| D: -2.31 (Book Value of Equity -1.07b / Total Liabilities 461.6m) |
| Altman-Z'' Score: -2.99 = D |
Beneish M -2.67
| DSRI: 0.98 (Receivables 272.3m/203.7m, Revenue 1.22b/901.4m) |
| GMI: 0.99 (GM 55.19% / 54.40%) |
| AQI: 1.51 (AQ_t 0.38 / AQ_t-1 0.25) |
| SGI: 1.36 (Revenue 1.22b / 901.4m) |
| TATA: -0.17 (NI -22.8m - CFO 178.4m) / TA 1.15b) |
| Beneish M-Score: -2.67 (Cap -4..+1) = A |
What is the price of ZETA shares?
Over the past week, the price has changed by -9.10%, over one month by -29.03%, over three months by -13.74% and over the past year by -19.42%.
Is ZETA a buy, sell or hold?
- StrongBuy: 8
- Buy: 3
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ZETA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 30.3 | 79.1% |
| Analysts Target Price | 30.3 | 79.1% |
| ValueRay Target Price | 19 | 12.5% |
ZETA Fundamental Data Overview February 03, 2026
P/S = 3.7308
P/B = 6.9471
P/EG = 0.8652
Revenue TTM = 1.22b USD
EBIT TTM = -24.7m USD
EBITDA TTM = 44.4m USD
Long Term Debt = 196.9m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 196.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -188.3m USD (from netDebt column, last quarter)
Enterprise Value = 4.38b USD (4.57b + Debt 196.9m - CCE 385.2m)
Interest Coverage Ratio = -35.59 (Ebit TTM -24.7m / Interest Expense TTM 694.0k)
EV/FCF = 28.14x (Enterprise Value 4.38b / FCF TTM 155.7m)
FCF Yield = 3.55% (FCF TTM 155.7m / Enterprise Value 4.38b)
FCF Margin = 12.71% (FCF TTM 155.7m / Revenue TTM 1.22b)
Net Margin = -1.86% (Net Income TTM -22.8m / Revenue TTM 1.22b)
Gross Margin = 55.19% ((Revenue TTM 1.22b - Cost of Revenue TTM 548.7m) / Revenue TTM)
Gross Margin QoQ = 55.39% (prev 56.43%)
Tobins Q-Ratio = 3.81 (Enterprise Value 4.38b / Total Assets 1.15b)
Interest Expense / Debt = 0.09% (Interest Expense 180.0k / Debt 196.9m)
Taxrate = 21.0% (US default 21%)
NOPAT = -19.5m (EBIT -24.7m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 3.01 (Total Current Assets 689.1m / Total Current Liabilities 228.8m)
Debt / Equity = 0.29 (Debt 196.9m / totalStockholderEquity, last quarter 689.2m)
Debt / EBITDA = -4.24 (Net Debt -188.3m / EBITDA 44.4m)
Debt / FCF = -1.21 (Net Debt -188.3m / FCF TTM 155.7m)
Total Stockholder Equity = 679.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -2.26% (Net Income -22.8m / Total Assets 1.15b)
RoE = -3.36% (Net Income TTM -22.8m / Total Stockholder Equity 679.0m)
RoCE = -2.82% (EBIT -24.7m / Capital Employed (Equity 679.0m + L.T.Debt 196.9m))
RoIC = -2.23% (negative operating profit) (NOPAT -19.5m / Invested Capital 875.6m)
WACC = 12.90% (E(4.57b)/V(4.77b) * Re(13.45%) + D(196.9m)/V(4.77b) * Rd(0.09%) * (1-Tc(0.21)))
Discount Rate = 13.45% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 16.49%
[DCF Debug] Terminal Value 67.00% ; FCFF base≈129.8m ; Y1≈160.1m ; Y5≈272.7m
Fair Price DCF = 11.12 (EV 2.28b - Net Debt -188.3m = Equity 2.47b / Shares 222.2m; r=12.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -4.95 | EPS CAGR: 38.41% | SUE: 0.85 | # QB: 1
Revenue Correlation: 97.43 | Revenue CAGR: 27.68% | SUE: 1.32 | # QB: 6
EPS next Quarter (2026-03-31): EPS=0.12 | Chg30d=-0.005 | Revisions Net=-1 | Analysts=13
EPS next Year (2026-12-31): EPS=0.97 | Chg30d=-0.023 | Revisions Net=-3 | Growth EPS=+45.0% | Growth Revenue=+34.2%